Life ScienceCompany
LigoCyte Pharmaceuticals Ownership
Who owns LigoCyte Pharmaceuticals?
LigoCyte Pharmaceuticals is owned by Takeda Pharmaceutical. It was acquired on October 4, 2012.
Was LigoCyte Pharmaceuticals formerly PE-backed?
Yes. LigoCyte Pharmaceuticals was formerly owned by 1 private investor.
LigoCyte Pharmaceuticals Business Overview
Where is LigoCyte Pharmaceuticals headquartered?
LigoCyte Pharmaceuticals is headquartered in Bozeman, Montana.
What sector is LigoCyte Pharmaceuticals in?
LigoCyte Pharmaceuticals is a life science company.
When was LigoCyte Pharmaceuticals founded?
LigoCyte Pharmaceuticals was founded in 1998.
Life Science M&A Summary in 2012
Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.
Join Mergr to view all 125 acquisitions of life science companies in 2012, including 18 acquisitions by private equity firms, and 107 by strategics.